1
|
M
|
46
|
Dizzy
|
Suprasellar
|
Craniotomy
|
GTR
|
Solid
|
Hypophysis, intracranial infection
|
S100(+), EMA(+), TTF-1(+), Ki-67 (2%)
|
12
|
No
|
2
|
F
|
46
|
None
|
Suprasellar
|
Craniotomy
|
GTR
|
Solid
|
Hypophysis
|
S100(+), GFAP(+), TTF-1(+), EMA(+), CD34(+), Ki-67 (1%)
|
34
|
Yes
|
3
|
F
|
47
|
Headache
|
Intrasellar
|
ETS
|
GTR
|
Solid
|
Hypophysis, intracranial infection
|
GFAP(+), TTF-1(+), CD34(+), S100(+), PR(+), EMA(+), Ki-67 (1%)
|
34
|
No
|
4
|
M
|
63
|
Vision loss
|
Intrasellar and suprasellar
|
ETS
|
STR
|
Uneven softness and toughness
|
None
|
S100(+), GFAP(+), TTF-1(+), EMA(+), Ki-67 (1%)
|
36
|
Yes
|
5
|
M
|
53
|
Vision loss
|
Intrasellar
|
Craniotomy
|
STR
|
Solid
|
None
|
S100(+), GFAP(+), TTF-1(+), EMA(+), vimentin(+), Ki-67 (1%)
|
88
|
Yes
|
6
|
M
|
32
|
Headache with decreased vision
|
Suprasellar
|
Craniotomy
|
GTR
|
Solid
|
Hypophysis
|
GFAP(+), S100(+), EMA(+), TTF-1(+), Ki-67 (1–3%)
|
24
|
No
|
7
|
F
|
51
|
Vision loss
|
Intrasellar
|
Craniotomy
|
STR
|
Uneven softness and toughness
|
Hypophysis
|
GFAP(+), S100(+), EMA(+), TTF-1(+), Ki-67 (1–5%)
|
22
|
Yes
|
8
|
F
|
65
|
None
|
Intrasellar and suprasellar
|
Craniotomy
|
STR
|
Soft
|
None
|
S100(+), GFAP(+), TTF-1(+), EMA(+), Ki-67 (1%)
|
12
|
No
|
9
|
F
|
38
|
Menstrual disorder
|
Suprasellar
|
Craniotomy
|
STR
|
Solid
|
None
|
GFAP(+), S100(+), EMA(+), TTF-1(+), CD34(+), Ki-67 (4%)
|
28
|
No
|
10
|
F
|
54
|
Headache
|
Intrasellar
|
ETS
|
GTR
|
Soft
|
None
|
S100(+), EMA(+), TTF-1(+), CD34(+), SMA(+), Ki-67 (1–3%)
|
22
|
No
|
11
|
M
|
47
|
Dizzy
|
Suprasellar
|
Craniotomy
|
GTR
|
Solid
|
Hypophysis and anemia
|
S100(+), EMA(+), TTF-1(+), Ki67 (2%)
|
16
|
No
|